Obesity is treated through a combination of lifestyle changes, medication, and in some cases surgery, with the approach depending on how much weight needs to be lost and whether weight-related health problems are already present. Losing even 5 to 10% of your body weight can meaningfully improve blood pressure, blood sugar, and cholesterol levels. Treatment typically starts with dietary and behavioral changes, then adds medication or surgery when those alone aren’t enough.
Why Small Amounts of Weight Loss Matter
One of the most important things to understand about obesity treatment is that you don’t need to reach an “ideal” weight to see real health benefits. A 5% loss for someone weighing 250 pounds is about 12.5 pounds. That modest reduction is associated with improved blood glucose levels, lower blood pressure, reduced cholesterol, better liver function, and gains in mobility and quality of life. This is why treatment guidelines focus on percentage of body weight lost rather than hitting a specific number on the scale.
Lifestyle and Behavioral Changes
Structured counseling focused on diet, exercise, and behavioral skills is the foundation of every obesity treatment plan. High-intensity programs typically involve weekly sessions for the first month, biweekly sessions for months two through six, and monthly check-ins after that. The behavioral component covers practical skills like meal planning, identifying eating triggers, and building motivation.
The results from lifestyle changes alone are real but modest. Adults with obesity who complete intensive counseling programs typically lose 3 to 5 kilograms (roughly 7 to 11 pounds) and sustain that loss for a year or more. For some people, that’s enough to hit the 5% threshold where health markers start improving. For others, it signals the need to add other treatments.
Dietary Approaches
No single diet works best for everyone, but structured approaches consistently outperform vague advice to “eat less.” In a recent 12-week clinical trial comparing a very low-calorie ketogenic diet to a standard reduced-calorie diet, the ketogenic group lost significantly more weight (about 27 pounds versus 15 pounds). More notably, 82% of the weight lost on the ketogenic diet came from fat rather than muscle, compared to only 38% in the standard diet group. The ketogenic group also saw larger improvements in fasting blood sugar, cholesterol, triglycerides, and blood pressure normalization.
That said, what matters most is whether you can stick with a dietary pattern long term. Structured programs with clear phases tend to support better adherence than open-ended calorie counting. The best diet for treating obesity is one that creates a consistent calorie deficit while preserving muscle mass and providing adequate nutrition.
Prescription Medications
Clinical guidelines strongly recommend adding medication when lifestyle changes alone haven’t produced enough weight loss. You’re generally a candidate if your BMI is 30 or higher, or 27 or higher with a weight-related condition like type 2 diabetes or high blood pressure.
The current FDA-approved options fall into a few categories:
GLP-1 based medications are the most effective options available right now. Semaglutide (Wegovy), given as a weekly injection, mimics a gut hormone that targets appetite-regulating areas in the brain. In clinical trials, half of people taking semaglutide at the treatment dose achieved at least 5% weight loss, compared to 12% on placebo. Liraglutide (Saxenda) works through the same mechanism but requires daily injections and produces somewhat less weight loss. Neither should be used by anyone with a personal or family history of medullary thyroid cancer.
Combination pills offer alternatives for people who prefer oral medications or can’t use GLP-1 drugs. Phentermine-topiramate (Qsymia) combines an appetite suppressant with a medication originally used for seizures and migraines, taken once daily. Naltrexone-bupropion (Contrave) pairs two medications that together reduce hunger and cravings, taken once or twice daily. Each has its own set of restrictions: Qsymia isn’t appropriate for people with glaucoma or an overactive thyroid, while Contrave isn’t safe for people with uncontrolled high blood pressure, a history of seizures, or those who use opioids.
Orlistat (Xenical) takes a completely different approach by blocking fat absorption in the gut. It’s taken three times daily with meals. It produces more modest weight loss than the newer options and can cause digestive side effects related to unabsorbed fat passing through the system.
Insurance and Access
Getting coverage for obesity medications has historically been one of the biggest barriers to treatment. Many insurance plans require prior authorization, documentation of failed lifestyle interventions, or step therapy (trying a cheaper medication first). Medicare has recently launched a voluntary model to negotiate directly with manufacturers of GLP-1 drugs for lower prices and standardized coverage terms, which could expand access significantly. If cost is a barrier, ask your provider about manufacturer savings programs or whether alternative medications with better coverage could work for you.
Bariatric Surgery
Surgery is the most effective treatment for severe obesity and has undergone a major shift in how it’s recommended. Updated guidelines from the American Society for Metabolic and Bariatric Surgery now recommend surgery for anyone with a BMI of 35 or higher, regardless of whether they have other health conditions. Surgery should also be considered at a BMI of 30 to 34.9 for people with metabolic diseases like type 2 diabetes, and at a BMI of 27.5 for Asian individuals, who tend to develop obesity-related complications at lower body weights.
The two most common procedures are gastric sleeve (removing a large portion of the stomach) and gastric bypass (rerouting the digestive tract to reduce both stomach size and calorie absorption). Both are typically performed laparoscopically, meaning smaller incisions and shorter recovery times. Most people spend one to three days in the hospital and return to normal activities within a few weeks.
Long-term data shows that surgery produces durable results, though some weight regain is normal. In a 12-year follow-up study of gastric bypass patients, 93% maintained at least a 10% weight loss from their starting weight, and 70% maintained at least a 20% loss. About 40% kept off 30% or more. These numbers reflect the reality that surgery is highly effective but not a permanent fix on its own. It works best when combined with ongoing dietary changes and follow-up care.
What’s Coming Next
The obesity treatment landscape is changing fast. Retatrutide, an investigational weekly injection that activates three different hormone receptors simultaneously (compared to one or two for current drugs), has shown striking results in clinical trials. At the higher dose, participants lost an average of 28.7% of their body weight over about 16 months, roughly 71 pounds for the average participant. That approaches the weight loss typically seen with surgery. Beyond the scale, participants with knee osteoarthritis experienced significant pain reduction, and systolic blood pressure dropped by 14 points. Side effects were primarily gastrointestinal: nausea, diarrhea, constipation, and decreased appetite. Multiple additional trial results are expected in 2026.
How Treatment Decisions Are Made
Obesity treatment isn’t one-size-fits-all, and most people end up using a combination of approaches. The general framework looks like this: everyone starts with or continues lifestyle modifications. If you haven’t lost enough weight after several months, medication gets added. If your BMI is high enough or you have significant health complications, surgery enters the conversation. Each step builds on the last rather than replacing it. People who have bariatric surgery still need to follow structured eating patterns. People on medication still benefit from behavioral counseling and exercise.
The shift in how medicine treats obesity over the past decade has been dramatic. It’s increasingly recognized as a chronic condition driven by hormones, genetics, and brain chemistry rather than a failure of willpower. That reframing matters because it changes the treatments offered, the insurance coverage available, and the long-term approach to management. Like other chronic conditions, obesity often requires ongoing treatment rather than a one-time intervention.